•New research confirms association of OSA with glaucoma•Omega Ophthalmics raises $7M to advance injectable IOL platform•Rosacea may double risk for DR progression•WaveFront Dynamics integrates B+L, Wave Eye Care scleral lenses•Side sleepers face higher risk of uneven glaucoma•New research confirms association of OSA with glaucoma•Omega Ophthalmics raises $7M to advance injectable IOL platform•Rosacea may double risk for DR progression•WaveFront Dynamics integrates B+L, Wave Eye Care scleral lenses•Side sleepers face higher risk of uneven glaucoma
HEADLINES
FEATURED
Primary endpoint not achieved in full dataset while ad-hoc analysis excluding asymmetric cohort demonstrated non-inferiority to on-label aflibercept.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
